Acceso a la atención médica Press Releases
The Trump administration issued an executive order Sunday that would significantly change how Medicare pays for certain prescription drugs. The “Most Favored Nation” policy would tie Medicare drug reimbursement for certain drugs under Part B and D to that of prices paid in select foreign countries.
Washington, D.C.—Patient groups representing millions of people with serious health conditions submitted an amicus brief
Gov. Murphy has included a cigarette tax increase and steady funding for crucial cancer programs. NJ Government Relactions Director Michael Davoli responds.
COLUMBIA, SC — August 21, 2020 — Alongside shining a bright light on growing health inequities, the COVID-19 pandemic has made it increasingly difficult for cancer patients and survivors to receive the care they need and has led to delays in preventive screenings, diagnostic test
Jefferson City, MO — Missourians approval of Amendment 2 will improve health outcomes and reduce cancer disparities for 230,000 citizens who will gain access to health insurance coverage through the state’s Medicaid program.
ST. PAUL, Minn. – Three pieces of legislation that reduce Minnesota’s cancer burden go into effect August 1st.
Today President Trump signed executive orders on pharmaceutical rebates, prescription drug importation and an International Pricing Index (IPI) or “Most Favored Nation” Model. The following is a response to the executive orders from the American Cancer Society Cancer Action Network (ACS CAN).
RALEIGH, NC – July 1, 2020 – Today, Gov. Cooper signed SB 361 into law officially enacting step therapy reform in the state. His signatures makes North Carolina the latest state alongside 20 others that have passed legislation to rehabiliate the “fail first” therapy process.
SPRINGFIELD, Ill. - The American Cancer Society Cancer Action Network (ACS CAN) is encouraged to see the Illinois legislature pass and Gov. J.B. Pritzker sign legislation to allow Illinois Medicaid recipients access to possible life-saving clinical trials.
Today the U.S. House of Representatives is expected to vote on a legislative package containing provisions aimed at improving access to affordable health care, including for those with serious pre-existing conditions like cancer.